Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $62.78 USD
Change Today -0.30 / -0.48%
Volume 1.1M
STJ On Other Exchanges
New York
As of 8:04 PM 11/24/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One St. Jude Medical Drive

St. Paul, MN 55117

United States

Phone: 651-756-2000

Fax: 651-756-3301

ve and steerable catheters. Its Supreme, Response and Inquiry fixed-curve catheters gather electrical information from the heart to help determine the cause of an arrhythmia and/or the location of its source. The company’s steerable product lines include Livewire and Inquiry catheters, which allow clinicians to move the catheter tip in precise movements to diagnose the more anatomically challenging areas within the heart. The company’s Reflexion Spiral (FDA approval) and Inquiry Optima PLUS (FDA approval) circular mapping catheters enable the physician to check for electrical isolation of the pulmonary vein openings during an AF ablation procedure. The Reflexion HD (FDA approval) and Inquiry AFocus II Double Loop (FDA approval) catheters are high-density, circular mapping catheters that are designed to leverage the mapping capabilities of the EnSite Velocity System to create high-density heart chamber models and detailed electrical maps. The company’s EnSite Velocity System is a mapping and navigation system that, when used in conjunction with the EnSite Array non-contact mapping catheter or EnSite NavX navigation and visualization technology, creates three-dimensional cardiac models, allows for intracardiac diagnostic and ablation catheters to be located and navigated without the use of fluoroscopy within those models and provides electrical activity to be displayed in a color-coded fashion. The EnSite Velocity System also includes various modules and tools to assist the physician with their EP procedure. The company’s OneModel tool facilitates the creation of detailed chamber models; its OneMap tool allows simultaneous creation of chamber models and the associated electrical data in one step; and its RealReview function allows the user to view live and pre-recorded cardiac models and electrical maps simultaneously. The company’s EnSite Derexi module facilitates the exchange of information between the EnSite Velocity System and the EP-WorkMate recording system, to help improve efficiency and procedural workflow. Its EnSite Courier module could import and export data sets to and from a hospital's Picture Archiving and Storage network. The company offers multiple ablation catheter configurations, which focus on disabling abnormal tissue that causes or perpetuates arrhythmias. The company’s standard non-irrigated tip ablation catheters include its Livewire TC Ablation Catheters uni- and bi-directional models that offer stability and contact with cardiac tissue. The company’s Safire and Safire TX bi-directional ablation catheter product line offers a range of catheter tip sizes (Safire 4mm and 5mm FDA approved in 2006 and Safire TX 8mm FDA approved in 2007) and curve configurations, and is built on the company’s ComfortGrip handle platform that is designed for physician comfort and control during EP procedures. The company’s Therapy 4mm and 8mm tip standard catheter lines provide a range of curve options and temperature control. When used with its 1500 T-series Cardiac Ablation Generators, power could be managed for the creation of ablation lines. In addition to the 1500 T-series Cardiac Ablation Generations, in March 2014 the Ampere RF Generator was approved by the FDA. This generator is compatible with the company’s approved ablation catheters. In addition to the standard non-irrigated tip ablation catheters, the company offers various open-irrigated ablation catheters, which feature holes at the tip of the catheter to allow infused saline to circulate around the tip during therapy delivery. This irrigation allows the tip to be cooled and reduces the potential for char or thrombus (blood clot) to form during ablation. The Therapy Cool Path Duo (European CE Mark approval) and the Safire BLU Duo (FDA approval) are both irrigated tip ablation catheters that feature 12 infusion ports that allow for more uniform cooling of the ablation tip. The Therapy Cool Flex irrigated ablation catheter (European CE Mark approval) is an irrigated, flexible tip ablation catheter that features a laser-cut tip, allowing it to bend and conform to the cardiac anatomy and providing for fluid to be infused around the entire catheter tip


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STJ:US $62.78 USD -0.30

STJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $186.24 USD -1.02
Olympus Corp ¥4,840 JPY -90.00
Smith & Nephew PLC 1,107 GBp -9.00
Terumo Corp ¥3,965 JPY -60.00
Zimmer Biomet Holdings Inc $101.92 USD -0.93
View Industry Companies

Industry Analysis


Industry Average

Valuation STJ Industry Range
Price/Earnings 17.9x
Price/Sales 3.2x
Price/Book 4.5x
Price/Cash Flow 16.1x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ST JUDE MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at